How to appeal an Aetna women's health — menopause, endometriosis, pcos, ppd denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Aetna-specific note: Owned by CVS Health since 2018. CVS Caremark is the PBM. Aetna ASA administers self-funded ERISA plans. Meritain Health is Aetna's TPA brand.

What Aetna's policy requires for women's health — menopause, endometriosis, pcos, ppd

Cited policy: Aetna CPB on Zurzuvae (Zuranolone) for PPD

PPD onset within 12 months postpartum. EPDS or PHQ-9 documentation. Psychiatrist or trained OB/GYN Rx. Step therapy through SSRI not formally required.

How Aetna denies women's health — menopause, endometriosis, pcos, ppd — and how to counter it

Where Aetna pushes back: 1) Try SSRI first; 2) PPD not documented within 12 months; 3) Severity insufficient.

Counter-arguments that hold up: SKYLARK Am J Psychiatry 2023 — 3-day separation from placebo. Rapid-onset critical in puerperium for maternal functioning + infant attachment. CANMAT/APA 2024 update recognizes new option. Document EPDS >=10 + onset within 12 months postpartum + maternal-infant interaction concerns.

What Aetna typically denies for women's health — menopause, endometriosis, pcos, ppd

Across Aetna's commercial and Medicare books, denials cluster around a small number of patterns. For women's health — menopause, endometriosis, pcos, ppd, expect:

• UM-2575 medical necessity denials
• Prior auth absent
• Step therapy on specialty drugs
• Out-of-network ER reduction

Treatments most often denied in this category

These are the women's health — menopause, endometriosis, pcos, ppd treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Veozah (hot flashes)
• Zurzuvae (PPD)
• Menopause HT
• Orilissa (endo)
• Myfembree
• Oriahnn (fibroids)

How to submit the appeal to Aetna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Aetna cited in the denial.
3. File the appeal through Aetna's portal (members: https://www.aetna.com ; providers: https://www.aetnaprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Aetna's prior-authorization criteria by drug: Aetna PA criteria on ApprovalHelp.